CS MEDICA A/S Secures Repurchase Orders from Key European Partners
CANNORDIC Continues Momentum with Recurring Orders of 45.000 Units from European Healthcare LeadersCS MEDICA, a pioneering MedTech company specializing in pain management and autoimmune diseases with innovative substance-based medical devices containing bioactive CBD, announces that its subsidiary, CANNORDIC, has received repurchase orders for 45,000 units from its German partner, Alsitan, and Spanish partner, Uriach, for delivery in Q3 and Q4, 2024. CANNORDIC hereby strengthens its market penetration with a total of 241,000 units in orders from the two leading European Healthcare